Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/1994
07/21/1994WO1994015592A1 Compositions comprising cholesterol lowering agents and antioxidants
07/21/1994CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
07/21/1994CA2153698A1 Olefin-substituted long chain compounds
07/21/1994CA2153241A1 Methods for promoting cartilage matrix formation
07/21/1994CA2152184A1 Thiazolidine derivatives; process for preparing the same and drugs containing them
07/21/1994CA2131370A1 Quinoline-3-acetic acid derivative, process for production thereof and use thereof
07/20/1994EP0606824A1 Substituted dialkylthioethers
07/20/1994EP0606742A1 Bile acid sequestrant
07/20/1994EP0606332A1 Method of producing starch decomposition products with a narrow molecular-weight distribution
07/20/1994EP0606318A1 Vanadium compositions
07/20/1994CN1089614A Alpha-phosphonosulfonate squalene synthetase inhibitors and method
07/20/1994CN1089599A Derivative of vitamin D system which is modified in 20-position, preparation of same and pharmaceutical made of same
07/20/1994CA2113580A1 Organic compounds
07/19/1994US5331009 Pharmaceutical compositions for treating adrenoleukodystrophy
07/19/1994US5330999 2,4-thiazolidinedione compounds
07/19/1994US5330977 Di-N-acetyl lysoganglioside compositions
07/19/1994US5330757 Method for the prevention and reversal of the extrinsic aging of the skin by transdermal application of selenamino acids and compositions therefore
07/19/1994CA1330806C Vitamin d_ derivatives having a substituent at 2-position
07/16/1994CA2112786A1 Substituted dialkylthio ethers
07/13/1994EP0606049A1 Aminoalkylphenyl compounds
07/13/1994EP0605983A2 Insulin analogs
07/13/1994EP0605913A1 Use of bile salt-activated lipase as dietary supplement
07/13/1994EP0605728A1 Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
07/13/1994EP0605484A1 Peptides having growth hormone releasing activity
07/13/1994EP0559751A4 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth)
07/12/1994US5328909 Cyclopropenone derivatives
07/12/1994US5328906 0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same
07/12/1994US5328903 Containing mannitol or sugar, hydroxypropyl cellulose, and polyvinylpyrrolidone or hydroxymethyl celulose; stabilization, uniform distribution
07/12/1994US5328891 DNA codes and proteins
07/12/1994US5328470 Catheter
07/12/1994CA1330663C Thiazolidinedione derivatives
07/07/1994WO1994014843A1 Endothelin antagonists
07/07/1994WO1994014786A1 Piperidine derivatives as calcium channel antagonists
07/07/1994WO1994014766A1 Novel vitamin d analogues
07/07/1994WO1994014461A1 Insulin analogs
07/07/1994WO1994014435A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
07/07/1994WO1994014433A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A β-LACTAM CHOLESTEROL ABSORPTION INHIBITOR
07/07/1994WO1994014429A1 Method of promoting nitrogen retention in humans
07/07/1994WO1994014411A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis
07/07/1994WO1994014347A1 A protective garment
07/07/1994CA2152912A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
07/07/1994CA2152394A1 Piperidine derivatives as calcium channel antagonists
07/07/1994CA2152163A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis
07/07/1994CA2151134A1 Insulin analogs
07/07/1994CA2146874A1 Endothelin antagonists
07/07/1994CA2112778A1 Aminoalkylphenyl compounds
07/06/1994EP0605230A1 Hexanhydronaphthalene ester derivatives, their preparation and their therapeutic uses
07/06/1994EP0605228A1 Thiazolidinedione derivatives, their production and use
07/06/1994EP0605193A1 Use of benzothiophenes for treatment of hypercholesterolaemia
07/06/1994EP0604983A1 Naphthalene derivatives
07/06/1994EP0604800A1 4- 4- 4-(carboxyalkyl)-phenyl amino carbonyl -phenyl -piperedines as aggregation inhibitors
07/06/1994CN1088835A Use of a peptide
07/05/1994US5326898 Substituted phenylethenyl compounds having retinoid-like biological activity
07/05/1994US5326757 Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
07/05/1994CA1330561C Synthetic gtf chromium material and process therefor
07/01/1994CA2086565A1 Pharmaceutical composition for treating pigmentation
06/1994
06/29/1994EP0603769A1 Alpha-Aminoketone derivatives
06/29/1994EP0603699A1 Substituted pyridines as HMG-CoA reductase inhibitors
06/29/1994EP0603649A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors
06/29/1994EP0480934B1 A slimming pharmaceutical composition
06/29/1994EP0470183B1 Fibroblast growth factor conjugates
06/29/1994EP0406272B1 Production of insulin-like growth factor binding protein
06/29/1994CN1088583A Phospholipi derivatives containing higher elements of the Vth main group
06/29/1994CA2112442A1 Hexahydroaphthalene ester derivatives, their preparation and their therapeutic uses
06/29/1994CA2112283A1 Thiazolidinedione derivatives, their production and use
06/28/1994US5324840 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
06/28/1994US5324749 Pharmaceutical aqueous solution of 4-[2-(benzene-sulphonylamino)-ethyl]-phenoxyacetic acid
06/28/1994US5324742 Antidiabetic agents
06/28/1994CA1330441C Process for trans-6-[2-(substituted-pyrrol-1-yl) alkyl] pyran-2-one inhibitors of cholesterol synthesis
06/28/1994CA1330420C Compositions containing growth hormone peptide fragments
06/28/1994CA1330417C Organic compounds
06/26/1994CA2111931A1 .alpha.-aminoketone derivatives
06/23/1994WO1994013816A1 Recombinant canine gastric lipase and pharmaceutical compositions
06/23/1994WO1994013696A1 Spiro piperidines and homologs which promote release of growth hormone
06/23/1994WO1994013676A1 Pyrrolopyrimidines as crf antagonists
06/23/1994WO1994013650A1 Heterocyclic derivatives and their use in pharmaceuticals
06/23/1994WO1994013645A1 Novel selective aromatase inhibiting compounds
06/23/1994WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
06/23/1994WO1994013300A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
06/23/1994WO1994013291A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives
06/23/1994WO1994013278A1 Methods for treatment with dimercaptosuccinic acid (dmsa)
06/23/1994WO1994013276A1 4-guanidinobutyramide for improving blood circulation
06/23/1994WO1994013275A1 Glaucoma treatment
06/23/1994CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
06/23/1994CA2151747A1 Methods for treatment with dimercaptosuccinic acid (dsma)
06/23/1994CA2151734A1 4-guanidinobutyramide for improving blood circulation
06/23/1994CA2150904A1 Novel selective aromatase inhibiting compounds
06/22/1994EP0602211A1 Use of growth factor igf-ii
06/22/1994EP0602172A1 A method for treatment of patients with chronic liver disease
06/22/1994EP0602149A1 Composition and method for reducing cholesterol concentration
06/22/1994EP0602026A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it
06/22/1994CA2111778A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines
06/22/1994CA2111631A1 Bile acid sequestrant
06/21/1994US5322848 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals
06/21/1994US5322697 Composition and method for inducing satiety
06/21/1994CA1330344C Tetrahydrocarbazole esters
06/21/1994CA1330304C Tissue irrigating solution
06/16/1994DE4241632A1 New (aza)aromatic or alicyclic carboxylic acid cpds. - used e.g. for treating thrombosis, inflammation, osteoporosis, cardiac infarct or tumour metastasis
06/15/1994EP0601573A1 Alpha-phosphonocarboxylate squalene synthetase inhibitors and method
06/15/1994EP0601135A1 Osteogenic proteins in the treatment of bone diseases